-
EP2705049
European procedure
Extract from the Register of European Patents
EP About this file: EP2705049
| EP2705049 - HEPATITIS C VIRUS INHIBITORS [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 25.08.2017 Database last updated on 06.07.2024 | Most recent event Tooltip | 31.01.2020 | Change - lapse in a contracting state | published on 04.03.2020 [2020/10] | Applicant(s) | For all designated states Bristol-Myers Squibb Company Route 206 and Province Line Road Princeton, NJ 08543 / US | [2016/42] |
| Former [2014/11] | For all designated states Bristol-Myers Squibb Company Route 206 and Province Line Road Princeton, NJ 05843-4000 / US | Inventor(s) | 01 /
HIEBERT, Sheldon c/o Landmark Collegiate 26 Centre Avenue East Landmark, Manitoba ROA OXO / CA | 02 /
RAJAMANI, Ramkumar c/o Bristol-Myers Squibb Company 5 Research Parkway Wallingford, Connecticut 06492 / US | 03 /
SUN, Li-Qiang c/o Bristol-Myers Squibb Company 5 Research Parkway Wallingford, Connecticut 06492 / US | 04 /
MULL, Eric c/o Bristol-Myers Squibb Company 5 Research Parkway Wallingford, Connecticut 06492 / US | 05 /
GILLIS, Eric P. c/o Bristol-Myers Squibb Company 5 Research Parkway Wallingford, Connecticut 06492 / US | 06 /
BOWSHER, Michael S. c/o Bristol-Myers Squibb Company 5 Research Parkway Wallingford, Connecticut 06492 / US | 07 /
ZHAO, Qian c/o Bristol-Myers Squibb Company 5 Research Parkway Wallingford, Connecticut 06492 / US | 08 /
MEANWELL, Nicholas A. c/o Bristol-Myers Squibb Company 5 Research Parkway Wallingford, Connecticut 06492 / US | 09 /
RENDUCHINTALA, Kishore V. 1D-402 Akme Harmony Bellandur Outer Ring Road Bellandur Bangalore, Karnataka 560 103 / IN | 10 /
SARKUNAM, Kandhasamy No. 1/962 H-Sivam Nagar ESI Ring Road Mookandapalli Krishnagiri District Hosur, Tamil Nadu 635 126 / IN | 11 /
NAGALAKSHMI, Pulicharla No. 90 Shwetaranga 6th Main, 13 D Cross Teacher's Colony 6th Avenue, Koramangala Bangalore, Karnataka 560 034 / IN | 12 /
BABU, P.V.K. Suresh Flat No.: 702 Park Golden Apartment Old Chandapura Hosur Road Bangalore, Karnataka 560 081 / IN | 13 /
SCOLA, Paul Michael c/o Bristol-Myers Squibb Company 5 Research Parkway Wallingford, Connecticut 06492 / US | [2014/11] | Representative(s) | Reitstötter Kinzebach Patentanwälte Sternwartstraße 4 81679 München / DE | [N/P] |
| Former [2016/42] | Reitstötter Kinzebach Patentanwälte Sternwartstrasse 4 81679 München / DE | ||
| Former [2014/11] | Reitstötter - Kinzebach Patentanwälte Sternwartstrasse 4 81679 München / DE | Application number, filing date | 12723993.7 | 01.05.2012 | [2016/42] | WO2012US35974 | Priority number, date | US201161482658P | 05.05.2011 Original published format: US 201161482658 P | US201261611171P | 15.03.2012 Original published format: US 201261611171 P | US201213459403 | 30.04.2012 Original published format: US201213459403 | [2014/11] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2012151195 | Date: | 08.11.2012 | Language: | EN | [2012/45] | Type: | A1 Application with search report | No.: | EP2705049 | Date: | 12.03.2014 | Language: | EN | The application published by WIPO in one of the EPO official languages on 08.11.2012 takes the place of the publication of the European patent application. | [2014/11] | Type: | B1 Patent specification | No.: | EP2705049 | Date: | 19.10.2016 | Language: | EN | [2016/42] | Search report(s) | International search report - published on: | EP | 08.11.2012 | Classification | IPC: | C07K5/12, A61K38/12, C07D487/04 | [2014/11] | CPC: |
A61K31/13 (EP,US);
C07D487/04 (EP,KR,US);
C07K5/0823 (US);
A61K31/4745 (EP,US);
A61K31/7056 (EP,US);
A61K38/06 (EP,US);
A61K38/2013 (EP,US);
A61K38/204 (EP,US);
A61K38/2053 (EP,US);
A61K38/21 (EP,US);
A61K38/212 (EP,US);
A61K45/06 (EP,US);
A61P31/12 (EP);
A61P31/14 (EP);
A61P43/00 (EP);
C07K5/0804 (EP,US);
C07K5/0827 (EP,US);
C07K5/12 (KR);
A61K38/00 (EP,US)
(-)
| C-Set: |
A61K31/13, A61K2300/00 (EP,US);
A61K31/4745, A61K2300/00 (EP,US);
A61K31/7056, A61K2300/00 (EP,US);
A61K38/2013, A61K2300/00 (US,EP);
A61K38/204, A61K2300/00 (US,EP);
A61K38/2053, A61K2300/00 (US,EP); | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2014/11] | Extension states | BA | Not yet paid | ME | Not yet paid | Title | German: | HEMMER DES HEPATITIS-C-VIRUS | [2014/11] | English: | HEPATITIS C VIRUS INHIBITORS | [2014/11] | French: | INHIBITEURS DU VIRUS DE L'HÉPATITE C | [2014/11] | Entry into regional phase | 16.11.2013 | National basic fee paid | 16.11.2013 | Designation fee(s) paid | 16.11.2013 | Examination fee paid | Examination procedure | 16.11.2013 | Examination requested [2014/11] | 23.06.2014 | Amendment by applicant (claims and/or description) | 18.11.2014 | Despatch of a communication from the examining division (Time limit: M03) | 10.12.2014 | Reply to a communication from the examining division | 16.06.2015 | Communication of intention to grant the patent | 26.10.2015 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 04.12.2015 | Communication of intention to grant the patent | 22.03.2016 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 22.03.2016 | Fee for grant paid | 22.03.2016 | Fee for publishing/printing paid | 24.05.2016 | Communication of intention to grant the patent | 02.09.2016 | Fee for grant paid | 02.09.2016 | Fee for publishing/printing paid | 02.09.2016 | Receipt of the translation of the claim(s) | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 18.11.2014 | Opposition(s) | 20.07.2017 | No opposition filed within time limit [2017/39] | Fees paid | Renewal fee | 31.03.2014 | Renewal fee patent year 03 | 12.05.2015 | Renewal fee patent year 04 | 10.05.2016 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | |||
| Former [2017/52] | deleted | ||
| Former [2017/31] | SE | 19.10.2016 | Cited in | International search | [A]WO03066103 (BOEHRINGER INGELHEIM PHARMA [US]) [A] 1-28 * page 6, line 6 - line 9; claim -; tables 4,5; compounds 739,740,824 *; | [A]US6608027 (TSANTRIZOS YOULA S [CA], et al) [A] 1-28 * page 90; claim -; table -; compounds 824,916 *; | [X]WO2004094452 (BRISTOL MYERS SQUIBB CO [US], et al) [X] 1-28 * page 4, line 17 - line 31; claim -; table - *; | [X]US2007099825 (D ANDREA STANLEY [US], et al) [X] 1-28 * paragraph [0011]; claim -; table - * * paragraph [0103] *; | [Y]WO2009070692 (ENANTA PHARM INC [US], et al) [Y] 1-28 * claim -; table -; compounds 50,70 *; | [Y]US7601709 (MIAO ZHENWEI [US], et al) [Y] 1-28 * pages 62,130; example 89; claim - *; | [A] - NI Z-J ET AL, "PROGRESS AND DEVELOPMENT OF SMALL MOLECULE HCV ANTIVIRALS", CURRENT OPINION IN DRUG DISCOVERY AND DEVELOPMENT, CURRENT DRUGS, LONDON, GB, (20040701), vol. 7, no. 4, ISSN 1367-6733, pages 446 - 459, XP009037092 [A] 1-28 * page 447, column l; figure - * | by applicant | - BERGER A.; SCHECHTER 1., TRANSACTIONS OF THE ROYAL SOCIETY LONDON SERIES, (1970), vol. B257, pages 249 - 264 | - PHARMACEUTICAL RESEARCH, (1986), vol. 3, no. 6, page 318 |